Albeit the roles of AZGP1 and IGF2BP2 in the immune response have not been investigated, our study was first to suggest that AZGP1 downregulation and IGF2BP2 upregulation may act as suppressors in tumor immune response in SCCHN. The gene discussed is AZGP1; the disease is neoplasm.